(Press-News.org) A research team at Washington University School of Medicine in St. Louis has identified potential new treatment targets for Alzheimer's disease, as well as existing drugs that have therapeutic potential against these targets.
The potential targets are defective proteins that lead to the buildup of amyloid in the brain, contributing to the onset of problems with memory and thinking that are the hallmark of Alzheimer's. The 15 existing drugs identified by the researchers have been approved by the Food and Drug Administration (FDA) for other purposes, providing the possibility of clinical trials that could begin sooner than is typical, according to the researchers.
In addition, the experiments yielded seven drugs that may be useful for treating faulty proteins linked to Parkinson's disease, six for stroke and one for amyotrophic lateral sclerosis (ALS). The new study, funded by the National Institute on Aging of the National Institutes of Health (NIH), is published July 8 in the journal Nature Neuroscience.
Scientists have worked for decades to develop treatments for Alzheimer's by targeting genes rooted in the disease process but have had little success. That approach has led to several dead ends because many of those genes don't fundamentally alter proteins at work in the brain. The new study takes a different approach, by focusing on proteins in the brain, and other tissues, whose function has been altered.
"In this study, we used human samples and the latest technologies to better understand the biology of Alzheimer's disease," said principal investigator Carlos Cruchaga, PhD, the Reuben Morriss III Professor of Neurology and a professor of psychiatry. "Using Alzheimer's disease samples, we've been able to identify new genes, druggable targets and FDA-approved compounds that interact with those targets to potentially slow or reverse the progress of Alzheimer's."
The scientists focused on protein levels in the brain, cerebrospinal fluid and blood plasma of people with and without Alzheimer's disease. Some of the proteins were made by genes previously linked to Alzheimer's risk, while others were made by genes not previously connected to the disease. After identifying the proteins, the researchers compared their results to several databases of existing drugs that affect those proteins.
"They are FDA-approved, and all of the safety data on the drugs is available," said Cruchaga, . "With what is already known about the safety of these drugs, we may be able to jump directly to clinical trials."
Cruchaga said the team's focus on protein levels in key tissues has certain advantages over prior efforts to identify genes linked to Alzheimer's.
"The classic genetic studies of Alzheimer's have attempted to correlate genetic mutations with disease, but we know that genes carry the instructions to build proteins and that diseases such as Alzheimer's occur when those protein levels get too high or too low," Cruchaga explained. "To understand the biology of Alzheimer's disease, we should look at proteins rather than only at genes."
As an example, Cruchaga pointed to the APOE gene, which was first linked to Alzheimer's risk decades ago. But even after all this time, it still has not clear how that gene contributes to the disease.
"In this study, we were able to see that APOE alters levels of several proteins in brain tissue and CSF," Cruchaga said. "We also saw changes in proteins linked to another gene called TREM2 that was associated with Alzheimer's risk more recently. Understanding how the protein levels are affected by these risk genes is helping us to identify pathways that lead to disease."
Past research has helped identify about 50 genetic signals linked to Alzheimer's, but only a handful of the genes responsible for those signals have been found. Cruchaga said that focusing on protein levels in tissue may help reveal what's happening with the other 40-plus genetic signals that appear to be connected to Alzheimer's risk.
The researchers analyzed proteins and genes from brain tissue, cerebrospinal fluid and blood plasma from samples gathered from 1,537 people in the U.S. The samples are stored at the Knight Alzheimer's Disease Research Center at Washington University. Half of the samples came from people with a clinical diagnosis of Alzheimer's disease; the other half came from study participants who are considered cognitively normal.
The researchers measured protein levels in the samples from the brain, CSF and plasma. Using statistical techniques, they then connected the protein levels to disease. There were 274 proteins linked to disease in study subjects' CSF, 127 in blood plasma and 32 in brain tissue.
They applied those findings and machine learning techniques to distinguish among the protein differences and zero in on some of the proteins that contribute to damage that leads to Alzheimer's.
"We have targets -- although I'm not saying all of these targets are going to work or that all of the compounds we identified are going to stop the progress of the disease -- but we have a real hypothesis," Cruchaga said. "And we expect it may be possible to move from these genetic studies into real clinical trials quickly. That's a big jump."
INFORMATION:
Yang C, et al. Genomic and multi-tissue proteomic integration for understanding the genetic architecture of neurological diseases. Nature Neuroscience, published online July 8, 2021.
This work was supported by the National Institute on Aging of the National Institutes of Health (NIH). Grant numbers R01 AG044546, P01 AG003991, Rf1 AG053303, R01 AG058501, U01 AG58922, RF1 AG058501, and R01 AG057777. Additional support from the Alzheimer's Association. The recruitment and clinical characterization of research participants at Washington University were supported by NIH P50 AG05681, P01 AG03991 and P01 AG026276.
Washington University School of Medicine's 1,500 faculty physicians also are the medical staff of Barnes-Jewish and St. Louis Children's hospitals. The School of Medicine is a leader in medical research, teaching and patient care, consistently ranking among the top medical schools in the nation by U.S. News & World Report. Through its affiliations with Barnes-Jewish and St. Louis Children's hospitals, the School of Medicine is linked to BJC HealthCare.
HOUSTON - Researchers from The University of Texas MD Anderson Cancer Center found specific intestinal microbiota signatures correlate with high-grade adverse events and response to combined CTLA-4 and PD-1 blockade treatment. The study, published today in Nature Medicine, also identified a potential new strategy to treat toxicity - while maintaining response - to combined immune checkpoint blockade through either IL-1R inhibition or manipulation of the gut microbiota.
Dual immune checkpoint therapy has contributed to progress in overall survival for many cancer types, including ...
One of the things the human brain naturally excels at is recognizing all sorts of patterns, such as stripes on zebras, shells of turtles, and even the structure of crystals. Thanks to our progress in math and the natural sciences, we are not limited to just seeing the patterns; we can also understand how they readily originate out of pure randomness.
A notable example of different natural patterns with a single mathematical explanation are Turing patterns. Conceived in 1952 by the renowned mathematician Alan Turing, these patterns arise as the solutions to a set of differential equations that describe the diffusion and reaction of chemicals satisfying a few conditions. Going well beyond pure chemistry, Turing demonstrated ...
Though writing by hand is increasingly being eclipsed by the ease of computers, a new study finds we shouldn't be so quick to throw away the pencils and paper: handwriting helps people learn certain skills surprisingly faster and significantly better than learning the same material through typing or watching videos.
"The question out there for parents and educators is why should our kids spend any time doing handwriting," says senior author Brenda Rapp, a Johns Hopkins University professor of cognitive science. "Obviously, you're going to be a better hand-writer if you practice it. But since people are handwriting less then maybe who cares? The real question is: Are there other benefits to handwriting that have to do with reading and spelling and ...
Seismic waves passing through the ground near Longyearbyen in the Adventdalen valley, Svalbard, Norway have been slowing down steadily over the past three years, most likely due to permafrost warming in the Arctic valley.
The trend, reported in a new study published in Seismological Research Letters, demonstrates how seismic monitoring can be used to track permafrost stability under global climate change. The study is part of a focus section in an upcoming issue of the journal on Arctic and Antarctic seismology.
Julie Albaric of the University of Bourgogne Franche-Comté, while employed at NORSAR (Norway), and colleagues ...
Coastal wetlands - such as salt marshes - provide even more flood protection than previously thought, reducing the risk to lives and homes in estuaries, a new study has revealed.
The researchers' simulations showed that wetlands that grow in estuaries, such as salt marshes, can reduce water levels by up to 2 metres and provide protection far inland up estuary channels.
This subsequently saved up to $38 (£27) million in avoided flood damage costs per estuary during a large storm thanks to the wetlands' role in preventing storm floods.
The research is timely as wetlands are facing growing threats from continued urban development. 22 of the largest 32 cities in the world - including London, New York and Tokyo - are built on low-lying land around estuaries, ...
Populist anti-foreign aid rhetoric works - but only fans of populist politicians are convinced by hostile messages about charity abroad, a new study shows. Those who distrust populist politicians are significantly less susceptible to these messages.
The research shows international aid institutions and non-populist politicians should not be unduly worried about the impact of populism on global development cooperation.
Those wanting to convince the public about the importance of foreign aid should focus on communicating their message transparently and clearly, and using local partnerships.
The research, by A. Burcu Bayram from the University of Arkansas and Catarina Thomson from ...
Concerns have been raised about the AstraZeneca and Johnson & Johnson vaccines regarding very rare but potentially fatal side effects related to low blood platelet counts and blood clots. Recently, reports also emerged that the Pfizer-BioNTech vaccine may cause a rare yet serious side effect: heart inflammation. Concerns about side effects may trigger vaccine hesitancy, which the WHO considers one of 'Ten threats to global health'. Securing sufficient acceptance of vaccines is a key challenge in defeating the coronavirus pandemic, both now and in the future.
How ...
What happens when climate change affects the abundance and distribution of fish? Fishers and fishing communities in the Northeast United States have adapted to those changes in three specific ways, according to new research published in Frontiers in Marine Science.
Becca Selden, Wellesley College assistant professor of biological sciences, and a team of colleagues examined how fishing communities have responded to documented shifts in the location of fluke and of red and silver hake. The team found that fishers made three distinct changes to their approaches: following the fish to a new location; fishing for a different kind of fish; and bringing their catch to shore at another port of landing.
Selden began this research as a postdoctoral ...
July 8, 2021 - Until relatively recently, opioids were a mainstay of treatment for pain following total hip or knee replacement. Today, a growing body of evidence supports the use of multimodal analgesia - combinations of different techniques and medications to optimize pain management while reducing the use and risks of opioids, according to a paper in The Journal of Bone & Joint Surgery. The journal is published in the Lippincott portfolio in partnership with Wolters Kluwer.
"Multimodal analgesia has become the standard of care for total joint arthroplasty as it provides superior analgesia with fewer side effects than opioid-only protocols," write Javad Parvizi, ...
Augmented reality (AR) is poised to revolutionise the way people complete essential everyday tasks, yet older adults - who have much to gain from the technology - will be excluded from using it unless more thought goes into designing software that makes sense to them.
The danger of older adults falling through the gaps has been highlighted by research carried out by scientists at the UK's University of Bath and the Bath-based charity Designability. A Paper describing their work has received an honourable mention at this year's Human Computer Interaction Conference (CHI2021) - the world's largest conference of its kind.
The study concludes that adults aged 50+ are more likely to be successful at completing AR-prompted tasks (such as 'pick up the cube' followed by 'move the cube to the blue ...
